Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 4, 2011
Cost-effectiveness analysis of the Spanish renal replacement therapy programGuillermo Villa, Lucía Fernández-Ortiz, Jesús Cuervo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 2011
Cost analysis of the Spanish renal replacement therapy programmeGuillermo Villa, Ana Rodríguez-Carmona, Lucía Fernández-Ortiz, et al.
Journal of Medical Economics|January 19, 2017
Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer contextPeter P Toth, Mark Danese, Guillermo Villa, et al.
BMJ Open|April 29, 2022
Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UKMark Danese, Eduard Sidelnikov, Guillermo Villa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Estimation of a multiattribute utility function for the Spanish version of the TooL questionnaireAngel Luis Montejo, Javier Correas-Lauffer, Jorge Mauriño, et al.
Clinical Cardiology|April 20, 2016
Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United StatesShravanthi R Gandra, Guillermo Villa, Gregg C Fonarow, et al.
Health and Quality of Life Outcomes|November 14, 2019
Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trialsGian Luca Di Tanna, Joshua K Porter, Richard B Lipton, et al.
Upsala Journal of Medical Sciences|February 8, 2024
A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levelsMaria K Svensson, Stefan James, Annica Ravn-Fischer, et al.
Health and Quality of Life Outcomes|July 29, 2020
Utility value estimates in cardiovascular disease and the effect of changing elicitation methods: a systematic literature reviewMarissa Blieden Betts, Pratik Rane, Evelien Bergrath, et al.
Journal of the American Heart Association|September 8, 2022
Network Meta-Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid-Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low-Density Lipoprotein CholesterolPeter P Toth, Sarah Bray, Guillermo Villa, et al.
Pageof 5